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RATIONALE OF STUDIES 
The kinetic methods usually used for enzymatic studies only 
permit measurements with enzyme concentrations less than 1 ~g/ml, 
and very little enzyme kinetic data exist above this concentration. 
Enzyme concentrations in cells, however, are typically 1000 times 
more concentrated. At these high cellular enzyme concentrations, 
protein-protein interactions and enzyme polymerizations may occur, 
which might significantly alter the enzyme's properties from those 
found in the dilute assay solutions. Thus a major objective of 
our studies is to measure the catalytic properties of selected 
enzymes at concentrations comparable to their cellular levels. 
Enzymes which were suspected of undergoing polymerization upon 
increasing their concentrations from assay values ( < 1 ~g/ml) to 
cellular values (- 1 mg/ml) were chosen for study. A fast kinetic 
(stopped-flow) instrument permitted the rapid kinetic measurements 
needed with high enzyme concentrations. 
Another cause of altered kinetic properties at high enzyme 
concentrations exists for a few enzymes such as malate dehydrogenase 
and citrate synthase. With these enzymes, their concentrations in 
the cell equal or exceed their substrate concentrations, for example 
oxaloacetate and NADH. This may cause altered .equilibrium and kinetic 
properties of these reactions. 
In our project, we have also tried to avoid another deficiency 
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in most previous enzyme investigations, which generally studiously 
avoid physiological buffer components. Phosphate was avoided because 
it binds divalent metal ions and is thought to bind weakly to nucleo-
tide binding sites of enzymes, and because earlier measurements, which 
the investigator wishes to use for comparison, were made with phosphate 
free buffers. But phosphate is the principal cellular buffer ion, 
so we have chosen to use this and other ion components at concentra-
tions close to those that are estimated to exist in the cell. Studies 
in this laboratory (1) have shown, for example, that the catalytic 
properties of mitochondrial malate dehydrogenase are greatly altered 
by use of phosphate in place of the Tris buffer, which was used almost 
exclusively in previous investigations. 
This thesis reports studies on four different enzymes or enzyme 
pairs: porcine liver phosphofructokinase (PFK); chicken liver pyru-
vate carboxylase (PC); mitochondrial malate dehydrogenase-and citrate 
synthase coupled reactions (MDH-CS); and rat liver glucose 6-phosphate 
dehydrogenase (G6PD). PFK and G6PD are examples of enzymes that under-
go polymerization; PC was originally thought to polymerize, and the 
MDH-CS enzyme system is an example of enzymes with concentrations 
nearly equal to substrate concentrations. 
REFERENCE CITED 
(1) McGurk, K. S. R. (1976) Ph.D. Dissertation, Oklahoma State 
University. 
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CHAPTER 1 
PORCINE LIVER PHOSPHOFRUCTOKINASE 
4 
Introduction 
Phosphofructokinase (ATP: D-fructose 6-P-1-phosphotransferase, 
EC 2.7.1.11) (PFK) catalyzes the following reaction: 
D-fructose 6-phosphate + ATP --+ 
fructose 1,6-diphosphate + ADP + H+ 
It is cytosolic in its location although morphological changes 
occurring between sacrifice of animals and isolation of the enzyme 
cause it to be associated with particulate fractions (1,2,3). 
The reaction catalyzed by PFK is the rate limiting step in 
glycolysis. Cori first suggested its importance as the rate limiting 
step in the pathway (4) .. 
The control of the enzyme is extremely complex, including 
allosteric effectors, pH and concentration effects, and possibly a 
phosphorylation-dephosphorylation mechanism. 
If the terminology of Passonneau and Lardy (5) is used, the 
effectors of PFK can be divided into three categories: inhibitors, 
activators, and deinhibitors. An activator is distinguished from a 
deinhibitor in that it increases the velocity of the reaction at 
concentrations of ATP that are noninhibitory while a deinhibitor 
increases the reaction velocity at ATP concentrations that are 
inhibitory. Using this, one may generalize and say that inhibitors 
of PFK include ATP, citrate, Mg 2+, Ca 2+, phosphocreatine, 3-phospho-
glycerate, phosphoenolpyruvate, 2-phosphoglycerate, and 2,3-diphos-
phoglycerate. Activators of the enzyme are ammonium ion, potassium 
ion, inorganic phosphate, 5'-AMP, 3',5'-cyclic AMP, ADP, and fructose 
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1,6-diphosphate. Deinhibitors are fructose 1,6-diphosphate, 3',5'-
cyclic AMP, 5'-AMP, ADP, fructose 6-phosphate, inorganic phosphate, 
and glucose 1,6-diphosphate (6). Skeletal muscle PFK is known to 
exist in different molecular weight forms depending upon the pH and 
the enzyme concentration (7,8,9,10,11). Acid pH favors dissociation 
as does dilution. Both of these appear to proceed by the same 
mechanism (7). 
The enzymatic activity is dependent upon the state of aggregation 
of the enzyme (11,12). Forms smaller than the tetramer do not possess 
significant activity. Lad et al. (16) report that the specific 
activity of the rabbit muscle PFK decreases when it is diluted from 
a concentrated stock solution of greater than 10 mg/ml in a 0.1 M 
potassium phosphate, 1.0 rnM EDTA, p~ 8.0 buffer to a concentration 
of 0.15 mg/ml in a 0.1 M potassium phosphate, 1.0 rnM EDTA, and 1.0 or 
5.0 mM DTE, pH 7.0. They find that the final equilibrium specific 
activity and the rate at which the specific activity approaches 
equilibrium are dependent upon the final protein concentration. These 
changes in the specific activity reflect changes in the state of 
aggregation of the enzyme. 
Effectors appear to modify the effects of acid pH and dilution 
which cause a dissociation of the enzyme (10,12,13,14,15). For 
example, fructose 1,6-diphosphate at a concentration of 5.0 mM causes 
reassociation of PFK previously diluted to a concentration of 0.15 
mg/ml, and MgATP at a concentration of 5.0 mM (considered to be 
inhibitory) prevents dissociation of the enzyme upon dilution (16). 
Citrate, an inhibitor of PFK, appears to cause the higher polymeric 
forms of the enzyme to dissociate, and to stabilize the monomeric and 
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dimeric forms of the enzyme (16). 
Vinuela et al. presented evidence for a phosphorylation-dephos-
phorylation mechanism of PFK from yeast (17). The PFK existed in two 
forms, one sensitive to inhibition by ATP and citrate and the other 
insensitive. The insensitive form was believed to be the phosphory-
lated enzyme, the phosphorylation catalyzed by a "desensitizing 
protein." 
Further work by another group confirmed the existence of the 
sensitive and insensitive forms of PFK, but disagreed with the 
interpretation (18,19). They found that the conversion between the 
two forms of the enzyme is entirely mediated by effectors, and that 
the desensitizing protein did not catalyze a modification of the 
enzyme directly, but instead modified the assay system composition 
so that ATP, which prevents the transformation of a PFK form sensitive 
to ATP inhibition to one not sensitive, is converted to ADP which 
favors the conversion. The resulting enzyme is then more active. 
Other groups express the view that PFK exists in two conformational 
states (20,21). The conformation is believed to again be due to 
effectors. More recently, Brand and Soling have presented evidence 
for a phosphorylation-dephosphorylation mechanism for PFK from rat 
liver (22). This involves both an activating and an inactivating 
protein. The phosphate group appears to be attached to a serine 
residue in the protein. They show a decrease in enzyme activity 
concommitant with the release of Pi from the active protein. Hofer 
and FUrst have isolated a radioactive PFK from the skeletal muscle 
of mice previously injected with [ 32P]orthophosphate (23). Through 
acid hydrolysis, they too find evidence for the presence of an 
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0-phospho-L-serine residue in the protein. 
PFK from liver might differ from the same enzyme from skeletal 
muscle as liver is a gluconeogenic tissue while the skeletal muscle is 
a glycolytic tissue. In agreement with this expectation the liver 
and the muscle PFK's are actually different isoenzymes (24,25,26). 
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The rabbit isoenzymes differ in several respects (27). These include 
electrophoretic mobility, stability, molecular weight, and kinetic 
properties. For instance, the liver enzyme at pH 7.0 is more inhibited 
by ATP and less sensitive to the deinhibiting action of AMP, ADP, and 
c-AMP. It is less inhibited by citrate, phosphoenolpyruvate, phospho-
creatine, 2-phosphoglycerate and 3-phosphoglycerate, and more inhibited 
by 2,3-diphosphoglycerate. Because of the above differences, which 
suggest that the liver PFK is less suited to anaerobic energy pro-
duction, and because it is reported to undergo extensive polymerization 
(27), it appears to be an excellent candidate for study. 
Experimental 
Materials 
KH2POt., NH 4 Cl, K2S0 4 , and phenol were purchased from the Fisher 
Scientific Company; ultra pure EDTA and (NH4 ) 2S0 4 were from Schwarz-
Mann; and MgC1 2 came from Mallinckrodt. Tris base, 2-mercaptoethanol, 
tannic acid, gum arabic, ATP, ADP, F6P, FDP, and NADH came from the 
Sigma Chemical Company. The enzymes, aldolase, a-glycerol phosphate 
dehydrogenase, and triose phosphate isomerase were also from the 
Sigma Chemical Company. The a-glycerol phosphate dehydrogenase and 
triose phosphate isomerase were purchased as a mixture. Bovine 
serum albumin came from Pentex, while the pig livers were obtained 
from Ralph~s Packing Company, Perkins, Oklahoma immediately upon 
their removal from the animals. 
Methods 
Enzyme Purification. Immediately upon obtaining pig livers, 
they were placed in plastic freezer bags, closed, and frozen in 
powdered dry ice. They were then transported in this condition to 
the laboratory and stored at -25°C until needed. Livers were allowed 
to partially thaw in the cold room, 2-5°C, overnight before being 
used. The purification procedure used is that of Massey and Deal 
(28,29). The later reference is more informative and would be one's 
choice for instructions. 
One should pay great attention to the time of the year in 
procuring livers for this isolation. Massey and Deal mention that 
livers from winter animals provide the best source for the enzyme. 
It appears that only abnormally cold Oklahoma winters provide suitable 
material for this procedure. The warmer winters provide livers which 
result in difficulties in the solubilization-precipitation steps as 
the greatest portion of the enzyme remains insoluble. 
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Determination of Protein Concentration. The protein concentration 
is determined by the method of Katzenellenbogen and Dobryszycka as 
modified by Massey and Deal (29). The method is turbidimetric, 
making use of bovine serum albumin as the protein standard, tannic 
acid, and gum arabic which is used to stabilize the turbidity. Other 
methods of protein determination are unsuitable due to the high 
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concentrations of 2-rnercaptoethanol in this isolation procedure. 
Reagent Preparations. Substrate solutions were made and the pH 
adjusted the same day they were used. MgC1 2 used in the enzyme iso-
lation and in enzyme assays was purified using the method of Morrison 
and Uhr (30) in order to remove any heavy metals. 
Enzyme Assay. A coupled spectrophotometric assay was used to 
determine the activity of the PFK. Unless otherwise specified, the 
assay reaction mixture contained 50 mM Tris-Cl, 10 mM KH 2 P0 4 , 5 mM 
MgCl 2 , 50 mM 2-mercaptoethanol, 2 mM ATP, 4 mM F6P, 0.2 mM NADH, 
50 ~g/ml of the a-glycerol phosphate dehydrogenase and triose phos-
phate isomerase mixture, and 100 ~g/ml aldolase all at pH 8.0. The 
decrease in absorbance was monitored at 340 nm and 25°C. The activity 
was calculated using a value of 6.22 mM- 1 cm- 1 for the extinction 
coefficient of NADH. + Since two moles of NAD are formed for every 
mole of F6P converted to FDP, one unit of enzyme is defined as the 
conversion of 2.0 ~moles of NADH to NAD+ per minute. 
Instrumentation. All measurements were performed on a Coleman 
124 spectrophotometer. It is equipped with a No. 165 recorder, a 
No. 0319 thermostatted cell holder, a Haake model FS constant temper-
ature circulator, and a No. 801 scale expander. 
Results and Discussion 
Enzyme Purity 
Massey and Deal (28,29) have reported that pure porcine liver PFK 
has a specific .activity of 100 units per milligram of enzyme protein. 
All of the enzyme preparations used in this study had a specific 
activity of 100 upon completion of the purification. 
Investigation of Lag Times 
In the course of performing assays of the PFK a lag period was 
observed before a linear velocity was obtained. Increasing the 
concentration of the coupling enzymes did not reduce the lag. The 
lag has been reported previously, but the method used to deal with 
the lags was to read the velocity after a given period of time (27). 
In a limited study, we tried various treatments to assess their 
effect on the assay. Results are summarized in Tables I, II, and 
III. The reference buffer for the study was 50 mM Tris-Cl, 5 mM 
MgCl2, and 50 mM 2-mercaptoethanol. The enzyme was first diluted 
into an incubation mixture at 240 ].lg enzyme/ml and was then added to 
the assay cuvette to initiate the reaction at 1.2 ].lg enzyme/ml. 
Incubation times within conditions tested ranged between 1-20 
minutes with no significant changes in the lag time as a function 
of the time of incubation.. The addition of phosphate to the 
incubation and/or assay mixture increased lag times from about 33 
to 45 seconds (Table I). Nevertheless, since phosphate is a physio-
logical buffer, it was used in both incubation and assay solutions 
for the majority of tests. All combinations of a single substrate 
with a single product used in the incubation solutions increased 
11 
lag times relative to the reference condition. Incubation of the 
enzyme with both substrates (the last row of Table I), however, 
decreased the lag time noticeably, although it remained appreciable. 
If all of the substrates present in this test condition were converted 
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TABLE I 
STUDY OF LAG TIMESa 
P04 3 - in Time Before 
Additions to Incubation Mixture Assay Linearity, 
Medium seconds 
Yes 45.5 
No 33.0 
10 mM P0 4 3 - Yes 43.8 
4 mM F6P Yes 39.3 
4 mM F6P No 30.6 
Yes 54.1 
No 44.3 
4 mM F6P + 5 ~M FDP + 9 mM P0 43 - Yes 61.7 
4 mM F6P + 25 ~M FDP + 9 mM P0 43 - Yes 65.7 
2 mM ATP + 5 ~M FDP + 9 mM P0 43 - Yes 51.0 
2 mM ATP + 25 ~M FDP + 9 mM P0 43 - Yes 65.2 
4 mM F6P + 0.5 mM ADP + 9 mM P0 43 - Yes 49.7 
4 mM F6P + 1.5 mM ADP + 9 mM P0 43 - Yes 47.3 
2 mM ATP + 0.5 mM ADP + 9 mM P0 43 - Yes 47.5 
2 mM ATP + 1.5 mM ADP + 9 mM P0 43 - Yes 57.3 
Yes 40.3 
2 mM ATP + 4 mM F6P + 9 mM P0 43 - Yes 28.2 
aConcentrations of PFK in the incubation mixture and the assay 
mixture were 0.24 mg/ml and 0.012 mg/ml respectively. The incubation 
mixture was 50 mM Tris-Cl, 5 mM MgC1 2 , 50 mM 2-mercaptoethanol, pH 
8.0 plus the specified additions. The assay was performed as 
described under "Methods". 
TABLE II 
EVALUATION OF THE INCUBATION OF SUBSTRATE OR SUBSTRATE AND PRODUCT ON THE SPECIFIC ACTIVITYa 
4 mM F6Pb 4 mM F6P 4 mM F6P 2 mM ATP 2 mM ATP 4 rnl1 F6P 4 mM ADP 2 mM ATP 2 n~'l ATP 2 m}! ATP 
without Po,•- 4 mM F6P 5 IJM FDP 25 IJM FDP 5 1JN FDP 25 iJM FDP 0. 5 rnH ADP 1.5 mM ADP 0.5 mM ADP 1.5 mM ADP 
--
min S.A. min S.A. min S.A. min S.A. min S.A. min S .A. min S.A. min S.A. min S.A. min S.A. min S.A. 
0.83 91.9 7.17 98.7 3.10 70.6 3. 07 76.6 2.0 68.8 2.67 68.8 1. 67 69.4 3.32 79.6 2.95 73.9 2.50 67.4 1. 78 69.0 
4.17 90.6 10.08 101.0 8.00 93.0 7.50 82.5 8.0 78.0 8.12 78.9 7.50 93.9 8.25 90.6 8.18 83.1 7.58 91.2 6.12 85.2 
32.7 5 121.0 35.58 107.9 16.08 98.6 16.17 91.0 16.0 89.7 17.70 58. 9C 18.20 93.0 16.50 99.8 17.42 93.0 12.43 95.7 13.28 97.1 
38.50 113.3 
30.05 110.0 65.75 130.0 
60.03 127.6 68.05 122.0 
63.00 123.4 97.40 113.5 
90.03 116.0 
92.50 129.7 
aThe enzyme was diluted from a stock solution of 4.45 mg/ml in 50 mM Tris-Cl, 50 mH 2-mercaptoethanol, 110 mM (NH 4 ) 2 S0 4 , 5 IlL'! ~1gC1 2 , 0.1 mol ATP, and 0.1 
rnH FDP at pH 8.0 into the incubation buffer described in Table I. Assays were performed as described under "1,1ethods". 
bTwo separate experiments were run, as indicated by the space in the column. 
cThis value is lower than expected and is probably in error. 
1-' 
w 
TABLE III 
THE EFFECT OF PHOSPHATE ON THE SPECIFIC ACTIVITYa 
Incubation Times S.A. S.A. 
without Phosphate with Phosphate 
-
1 minute 103 92.4 
- 6 minutes 103 88.7 
- 15 minutes 97.5 88.7 
aThe incubation mixture contained 0.238 mg PFK/ml of a 50 mM Tris-C1, 
5 mM MgC1 2 , 50 mM 2-mercaptoethano1, pH 8.0 buffer either with or 
without 10 mM potassium phosphate as indicated. The assay was 
performed as described under "Methods" with 1.19 t.Jg PFK/ml. 
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to products, the resulting 200-fold dilution into the assay mixture 
would decrease ADP to 1 ~M and FDP to 2 ~M, concentrations too low to 
affect the maximal velocity determination. 
Specific Activity Dependence on Time of 
Incubation and Enzyme Concentration 
15 
The lag time studies showed some interesting trends. The enzyme, 
incubated at a concentration of 0.22 mg/ml with either one substrate or 
one substrate and one product shows an increase in specific activity 
(Table II). This increase is at times as great as 40 percent in less 
than 15 minutes of incubation. Incubation of the enzyme at a concen-
tration of 0.24 mg/ml without substrate or product results in no 
increase in the specific activity (Table III). 
Because the lag was least pronounced when starting the assay with 
PFK incubated with both substrates it was decided to initiate the 
assay in this manner. The standard assay composition described in 
the "Methods" section was used throughout the studies. Varying 
concentrations of the PFK were incubated with F6P and ATP as indicated 
in Tables IV-VII. Aliquots were taken at specified times and assayed. 
The incubation mixture was diluted two hundred fold into the assay 
cuvette. As can be seen, the enzyme incubated at a concentration of 
0.153 mg/ml shows a specified activity of about 110 units/mg and does 
not change with the time of incubation. Enzyme incubated at a con-
centration of 0.096 mg/ml shows an increased specific activity (about 
180 units/mg), but again does not appear·to change significantly with 
the incubation time. Dramatic results begin to appear at a concen-
tration of 15 ~g of PFK/ml of the incubation mixture (Table VI). 
TABLE IV 
INCUBATION AND ASSAY OF 0.153 mg PFK/ml, SPECIFIC ACTIVITIESa 
Incubation Time, Trial Number 
Minutes and Average 
Seconds 1 2 3 
1' 50" 100.8 104.8 125.8 110.5 
5' 20" 98.0 105.9 120.3 108.1 
12' 00" 109.0 114.0 121.0 114.7 
23 I 00" 112.0 
a The enzyme was incubated with 8 rnM ATP and 16 mM F6P in the assay 
buffer described in the "Methods" section. The assay is described 
in the "Methods" section. 
TABLE V 
INCUBATION AND ASSAY OF 0.0959 mg PFK/ml, SPECIFIC ACTIVITIESa 
Incubation Time, Trial Number 
Minutes and Average 
Seconds 1 2 3 
1' 50" 148 191.8 180.8 173.5 
5' 20" 183.5 177.8 176.7 179.3 
12' 00" 191.8 191.2 181.1 188.0 
23' 00" 188.5 176.1 186.5 183.7 
aThe enzyme was incubated with 10 mM ATP and 20 mM F6P in the assay 
buffer described in the "Methods" section. The assay is also 
described in the "Methods" section. 
16 
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TABLE VI 
INCUBATION AND ASSAY OF 0.0153 mg PFK/ml, SPECIFIC ACTIVITIESa 
Incubation Time, Trial Number 
Minutes and Average 
Seconds 1 2 3 
1' 50" 366.8 270.4 310.2 315.8 
5' 20" 807 622.5 643.5 691.0 
12' 00" 926.5 855.2 763 848.2 
23' 00" 815 962.1 813.3 863.5 
aincubation and assay of the enzyme are as in Table IV. 
TABLE VII 
INCUBATION AND ASSAY OF 9.59 ~g PFK/mla 
Incubation Time Specific Activity Minutes and Seconds 
1' 50" 224.7b 
5' 20" 583.6b 
12' 00" 1227 
23' 00" 1563 
35' 00" 1570 
45' 00" 1667 
61' 20" 1650 
81' 05" 1593 
aThe incubation and assay of the enzyme are as in Table V. 
b These values are lower than expected and may be in error. 
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Here the initial specific activity is increased almost three fold 
over the enzyme incubated at a concentration ten times higher. A 
time effect is also present, with the enzyme increasing in specific 
activity with increasing incubation time. Again, startling results 
are obtained when the enzyme is incubated at 9.59 ~g/ml. The specific 
activity increases to a value greater than 1600 units/mg upon incu-
bation for 45 minutes (Table VII). 
The time dependence for these cases is pictured in Figure 1 
where the more dilute enzyme is seen to increase in activity to a far 
greater extent than the more concentrated enzyme and the time of 
activation is longer. The dependence of the "infinite time" specific 
activity on the enzyme concentration is depicted in Figure 2 and 
Table VIII. Again the increase in specific activity with decreasing 
enzyme concentration is seen. 
The dramatic increase in the specific activity appears to require 
an enzyme dissociation-association equilibrium with more active 
subunits. Since the increased activity with decreasing enzyme concen-
tration does not occur in the absence of substrate (Table III), the 
dissociation equilibrium appears to be coupled to the preferential 
binding of the substrates to the dissociated enzyme, as in scheme 1, 
K1 V1 
E4 + 4S ~ E4S4 E4 + 4P  
Jr 
(1) 
K2 v2 
4E + 4S ~ 4ES 4E + 4P -:-----
where E represents PFK. This necessitates that the binding constant 
K2 > K1 , and the maximal velocity V2 > V1• In view of the evidence 
Figure 1. The Dependence of PFK Specific Activity in the Enzyme 
Concentration and Time During Incubation. Incubation 
and assay of the enzyme are as in Tables VI and VII. 
Enzyme concentrations are: 9.59 ~g/ml, 0--0; 15.3 
~g/ml, []--[]. The values plotted are averages of 
three experiments at 15.3 ~g PFK/ml, but a single 
experiment at 9.6 ~g PFK/ml. 
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experimental determination, the rest are averages of 
three determinations. 
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TABLE VIII 
COMPARISON OF ENZYME CONCENTRATION, INCUBATION TIMES, AND 
SPECIFIC ACTIVITIESa 
Concentration Incubation 
mg/ml 1' SO" 23' 00" Equilibrium 
0.153 110 .s 112 .o 112.0 
0.0959 173.5 183.7 183.7 
0.0153 315.8 863.5 863.5 
0.00959 224. 7b 1563 1650 
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Value 
aThe incubation and assay of the enzyme are as in the previous tables. 
bThis value is lower than expected and is probably in error. 
for enzymes modifying PFK (22) however, the possibility that a PFK 
kinase impurity exists with preferential activity toward dissociated 
enzyme in the presence of substrates should also be considered. 
Though further experiments would greatly clarify the mechanism, 
we have been unable to pursue them, since repeated attempts to purify 
more enzyme have failed. Eight purifications were attempted with 
the inability in all of them to solubilize the enzyme after having 
precipitated it. The effects described above, however, were seen 
with two different preparations. 
Summary and Conclusion 
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Incubation and assay of porcine liver PFK in a buffer containing 
10 mM potassium phosphate lead to increased lag times over the enzyme 
assayed in the same buffer without phosphate. Incubating the enzyme 
with both of its substrates reduced this lag. Incubation of the 
enzyme with one substrate, or with one substrate and one product 
resulted in an increasing specific activity with time. When the PFK 
was incubated with both of its substrates, an enzyme concentration 
dependent increase in specific activity occurred. The increase in 
specific activity is greatest with an enzyme concentration of 9.6 
wg/ml PFK where a specific activity of 1650 U/mg is observed (100 U/mg 
is the previously reported maximum). An enzyme dissociation-associa-
tion equilibrium with preferential binding of the substrates to the 
dissociated enzyme is proposed, although the possibility of a PFK 
kinase impurity with preferential activity toward dissociated enzyme 
in the presence of substrates is not eliminated yet. 
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CHAPTER II 
CHICKEN LIVER PYRUVATE CARBOXYLASE 
27 
Introduction 
Pyruvate carboxylase (pyruvate: C0 2 ligase (ADP); EC 6.4.1.1) 
catalyzes the following reaction: 
pyruvate + MgATP 2 - + HC0 3 -
acetyl-GoA 
'Me+, Me 2 + 
oxaloacetate + MgADP- + p.2 1 
where Me+ is a univalent cation and Me 2 + is a divalent cation. 
The chicken liver enzyme is converted from an essentially 
inactive form to the active form by the binding of acetyl-GoA. 
This conversion of the enzyme from an inactive to an active form 
is apparently due to a conformational transition (1,2). Previous 
measurements indicated a large increase in the enzyme's acetyl-GoA 
activation constant (the concentration of acetyl-GoA required 
to give half of the enzyme maximal activity) when the concentration 
of the pyruvate carboxylase was increased above 10 U/mg (0.7 mg/ml) 
(3). Enzyme association from the normal tetrameric form to octamers 
at high enzyme concentrations has been reported (1,4). The effective 
cellular concentration of pyruvate carboxylase has been estimated to 
be greater than 20 mg/ml (1), so that altered properties at high 
enzyme concentrations relative to the usual low assay concentrations 
(- 0.002 mg/ml) are relevant to its physiological properties. 
McGurk (2), using ANS-fluorescence studies, confirmed confor-
mational changes in pyruvate carboxylase with the addition of 
acetyl-GoA to the enzyme, and also with the addition of MgATP. The 
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fluorescence quenching accompanying the conformational change occurred 
within 4 ms of mixing the enzyme with the respective ligand, indica-
ting that the half times of activation are less than 4 ms, when 
acetyl-CoA was added or already present. 
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In this study we attempt to determine whether there is a correla-
tion between the rate of catalytic activation of pyruvate carboxylase 
by acetyl-CoA and MgATP and the rate of enzyme conformational transi-
tions induced by these ligands and reported by McGurk. We also 
reexamine the reports of Hill (3) that the acetyl-CoA activation 
constant increases as the enzyme concentration is increased, and that 
the specific activity of the enzyme decreases as the enzyme concen-
tration is increased. 
Experimental 
Materials 
Tris base, PMSF, DTNB, DTE, ATP, NADH, LiCoA, sucrose, Sephadex 
A-50, and Sephadex G-50 were purchased from the Sigma Chemical Company; 
ultrapure EDTA and ammonium sulfate were from Schwarz-Mann; and oxalo-
acetate was from Calbiochem. Pyruvic acid was supplied by the Aldrich 
Chemical Company; MgC1 2 was from Mallinckrodt; KH 2 P0 4 , acetic anhy-
dride, and KHC0 3 came from Fisher Scientific. Porcine heart malate 
dehydrogenase was purchased from Sigma, citrate synthetase from 
Boehringer, and BSA was from Pentex. Cornish-White Rock cross chicks 
were purchased from the Stillwater Hatchery. 
Methods 
Reagent Preparations. MgC1 2 was further purified by the method 
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of Morrison and Uhr (5). Pyruvic acid was vacuum distilled twice 
and stored frozen as a 1 M solution. The acetyl-GoA was prepared from 
LiCoA and acetic anhydride as suggested by Frey· and Utter (6). The 
LiCoA was dissolved in ice cold 0.1 M KHC0 3 and acetic anhydride at 
approximately 134% the molar concentration of the LiCoA was added 
(this is the amount of acetic anhydride necessary to give a negligible 
amount of unreacted LiCoA as determined with DTNB). The reaction 
mixture was kept cold at all times. The pH of the acetyl-GoA was 
adjusted just prior to use to the value desired in the measurements. 
The acetyl-GoA was assayed with citrate synthetase, oxaloacetate, and 
DTNB (7). ATP stock concentrations were calculated from spectrophoto-
metric data assuming£= 15,400 Mr 1 cm- 1 at 259 nm (8). 
Coupling Enzyme Preparation. The ammonium sulfate precipitate of 
malate dehydrogenase was collected by centrifugation and then dialyzed 
4-5 times against 100 volumes of 10 mM potassium phosphate buffer, 
1 rnM EDTA, 8.58 mM MgC1 2 , 2 rnM DTE, pH 7.6. 
Pyruvate Carboxylase Purification. The method of Scutton and 
Fung (9) was used in the purification of the pyruvate carboxylase. 
The livers of 9-10 week old Cornish-White Rock chickens (starved 36 
hours prior to sacrifice) were used for the purification. Purified 
enzyme was stored at pH 7.2 in 1.5 M sucrose, 0.025 M KP0 4 , 0.05 M 
(NH 4 ) 2 S0 4 , 1 mM EDTA, 2 mM DTE, and 2 ~M PMSF at 5°C. The Sephadex 
G-25 colunm used in the purification was replaced with a 1.5 hour 
dialysis against 3 liters of 0.025 M potassium phosphate buffer, 
2 mM EDTA, 5 mM 2-mercaptoethanol, 2 ~M PMSF, pH 7.2. Prior to use, 
pyruvate carboxylase was passed over a Sephadex G-50 (medium) column 
at room temperature to remove sulfate. 
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Enzyme Assays. Malate dehydrogenase was assayed at 340 nm and 
25°C. The assay mixture was 10 mM potassium phosphate, 1 mM EDTA, 
8.58 mM MgCl 2 , 2 mM DTE, 0.1 mM oxaloacetate, 0.2 mM NADH, all at pH 
7.6. One unit of malate dehydrogenase was defined as the conversion 
of 1 ~mole of NADH to NAD+ per minute. An absorptivity of 6.22 mM- 1 
cm- 1 was used for NADH. Pyruvate carboxylase was assayed spectra-
photometrically at 340 nm and 25°C by coupling the reaction with 
malate dehydrogenase. The functional definition of one unit of enzyme 
is again the conversion of 1 ~mole of NADH to NAD+ per minute. The 
assay mixture consisted of 10 mM potassium phosphate, 1 mM EDTA, 
8.58 mM MgCl 2 , 2 mM DTE, 10 mM pyruvate, 2 mM ATP, 15 mM KHC0 3 , 
0.1 mM acetyl-CoA, 0.2 mM NADH, and about 5 U/ml malate dehydrogenase, 
all at pH 7.6. The reaction was initiated by the addition of pyruvate 
carboxylase. 
The protein concentration was determined by the method of Kalckar 
(10) and increased by a factor of 2.0 (11). Thus these specific 
activities are two fold lower than those reported before this correc-
tion was determined. 
Instrumentation. Assays were performed at 25°C in a Coleman 124 
spectrophotometer and stopped-flow apparatus as described in the 
glucose 6-phosphate dehydrogenase studies. 
Results and Discussion 
Rates of Enzymatic Reactions Following 
Addition of Acetyl-CoA or MgATP 
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The rates of pyruvate carboxylation were measured at high enzyme 
concentrations to correlate rates (or lower limits of rates) of enzyme 
activation by acetyl-CoA or MgATP with the rates of induced conforma-
tional changes seen by McGurk (2), and to test for changes in the 
acetyl-CoA activation constant, Ka, with increased enzyme concentration 
as observed by Spivey and Hill (12). A high pyruvate carboxylase 
concentration was chosen so that its activity could be calculated 
from a segment of the progress curve (- 2 ~M extent of reaction) within 
2 milliseconds after the flow was stopped, assuming the enzyme would 
develop maximum activity during the 4 milliseconds of flow dead-time. 
Malate dehydrogenase concentrations were chosen so that the time to 
achieve 90 percent of the steady-state velocity in the coupled 
reaction was about 1.0 millisecond (13). Using the convention, 
[A] + [B], to represent rapid mixing of reactants A, stored initially 
in one drive syringe, with reactants B stored initially in the second 
syringe, the experiments were made with [acetyl-CoA + pyruvate] + 
[enzymes + MgATP + HC0 3 + MgC1 2 + NADH] to measure enzyme activation 
times by acetyl-CoA, and a similar distribution except for interchange 
of acetyl-CoA and MgATP to measure duration of the presteady-state 
response of enzyme to MgATP addition. 
Maximum enzyme specific activities were found at the earliest 
times measurable (4 milliseconds dead-time + 2 milliseconds subsequent 
reaction time) in both types of experiments, showing that the half 
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lives of enzyme activation were less than 2 milliseconds. The specific 
activities at these high enzyme concentrations (14.3 U/mg at 1.27 
mg/ml) and 0.1 mM acetyl-CoA were the same as with dilute enzyme 
(0.0023 mg/ml) within experimental error. These results contrast 
with previous measurements (3,12) where greatly reduced enzyme specific 
activities (due to apparent increased acetyl-CoA activation constant) 
and relatively slow (hysteretic) responses to addition of acetyl-CoA 
(t1 - 0.2 second) or MgATP (t1 - 0.25 second) were observed as enzyme ~ ~ 
concentrations were increased above about 0.7 mg/ml. 
The conformational changes in pyruvate carboxylase monitored by 
McGurk (2) through ANS fluorescence occurred faster than the 4 
millisecond dead-time of the stopped-flow spectrophotometer. Similar-
ly, the activation times for acetyl-CoA and MgATP, as determined in 
this study, were within the 4 millisecond dead-time of the apparatus, 
suggesting a correlation between the activation times and the confor-
mational change observed in the enzyme. 
Possible Reasons for Differences Between Current 
and Past Results 
In the previous study by Hill (3), reactions were started by rapid 
addition of pyruvate to enzyme incubated with acetyl-CoA and all other 
substrates. Thus no hysteretic transitions were observed at any of the 
enzyme concentrations examined. Sufficiently small increments in 
enzyme concentration were used for each experiment to give extensively 
overlapping times of the initial velocity periods between experimental 
records. Thus a hysteretic transition was rigorously excluded as the 
cause of the reduced enzymic activities observed by Spivey and Hill 
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(3,12). Rates of acetyl-CoA hydrolysis were far too slow to account 
for the reduced activity; nor was the enzyme concentration (0. 5 - 1.0 
mg/ml) sufficient to bind enough of the total acetyl-CoA (100 ~M) to 
explain the results. It does not appear reasonable to blame the 
results on a low molecular weight impurity, since the Sephadex G-50 
column decreased the 50 mM (NH 4 ) 2 S0 4 used in the enzyme storage buffer 
to below detection limits by BaC1 2 or Nessler's reagents prior to 
using the enzyme. 
Therefore the most reasonable possibilities explaining the 
difference between previous and current results are: 1) different 
buffers; the more recent experiments were done with enzyme in 
phosphate buffer due to instances of extreme enzyme lability in the 
Tris buffer previously used, and 2) the higher enzyme purity (by 
about 2-fold) in current experiments. 
Recent measurements of the enzyme-acetyl-CoA dissociation 
constant at higher enzyme concentrations (14) support our more recent 
observations, since the dissociation constant so determined agrees 
very well with the acetyl-CoA activation constant with dilute 
enzyme, and is far too low (13.9 ~M) to explain the reduced activity 
observed by Hill (3) and Spivey and Hill (12) with 100 ~M acetyl-CoA. 
Furthermore the conditions causing enzyme polymerization are not 
understood, and subsequent attempts to achieve appreciable enzyme 
polymerization have failed (15). The majority of the evidence then 
indicates that the enzyme's specific activity is independent of 
enzyme concentration. This suggests that other reasons must be sought 
to explain acetyl-CoA regulation of the enzyme in vivo. Further 
stopped-flow measurements would be desired, however, if extensive 
enzyme polymerization is achieved in the future. 
Regulation of Pyruvate Carboxylase 
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Recent extensive, but as yet unpublished, work by Barritt, Zander, 
and Utter (16) has studied the question of whether, and how acetyl-GoA 
regulates the enzyme's activity in vivo. They calculate that a large 
fraction of the total cellular acetyl-GoA in the mitochondrial matrix 
(100 to 1500 ~M) could be bound to matrix proteins, which would raise 
the apparent activation constant to about 145 ~M acetyl-GoA. Perhaps, 
then an increase in the acetyl-GoA activation constant as a result of 
enzyme polymerization is unnecessary to provide enzyme regulation. 
Using isolated chicken liver mitochondria, they also find a correlation 
between the rate of pyruvate carboxylation and the mitochondrial 
acetyl-GoA concentration generated by exogenous acetylcarnitine in the 
presence of arsenite. These calculations and results suggest that 
acetyl-GoA variations in vivo can regulate pyruvate carboxylase 
activity. 
Summary and Conclusion 
The times of activation of pyruvate carboxylase by acetyl-GoA and 
MgATP are less than the 4 millisecond dead-time of the stopped-flow 
apparatus. These times correspond to those reported by McGurk (2) 
for the conformational change induced in the enzyme by these ligands. 
The activation is apparently due to the conformational change of the 
enzyme. These measurements suggest that there is no change in specific 
activity of pyruvate carboxylase with increasing enzyme concentration, 
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leading to the conclusion that this is not a means for cellular control 
\ 
of the enzyme. Recent measurements and calculations from Utter's lab 
(16) suggest that regulation of pyruvate carboxylase by varying acetyl-
CoA concentrations in vivo does occur, however, perhaps due to the high 
concentration of protein binding sites for acetyl-CoA in mitochondrial 
matrix. 
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CHAPTER III 
COUPLED EQUILIBRIA OF PORCINE HEART MITOCHONDRIAL 
MALATE DEHYDROGENASE AND CITRATE SYNTHASE 
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Introduction 
Srere (1) aptly pointed out that enzymological research has as 
its goal the explanation and the prediction of the metabolic behavior 
of cells and tissues. The study of purified enzymes is used to 
further this goal. This study looks at the coupled equilibria of 
the porcine heart mitochondrial malate dehydrogenase (L-malate:NAD 
oxidoreductase, EC 1.1.1.37) (MDH) and citrate synthase (citrate 
oxaloacetate lyase (CoA-acetylating), EC 4.1.3.7) (CS). 
The mitochondrial concentrations of MDH and CS substrate binding 
sites (30-50 ~M in enzyme subunits) are of the same magnitude as 
mitochondrial oxaloacetate and NADH concentrations (2). These 
enzyme bound substrate concentrations may exceed those of free 
substrates. This situation can cause significantly different kinetic 
and equilibrium properties of the catalyzed reactions from those 
determined with dilute enzymes, where enzyme concentrations are about 
1 nM. Calculation of these effects, though straightforward in 
principle, is not yet practical since the enzyme binding constants 
determined experimentally are with greatly different and simpler 
conditions from those in vivo. The experimental NADH and NAD+ 
binding constants to MDH, for example, may be greatly modified by 
the presence of oxaloacetate (3). Srere has found too that the 
calculated activity of CS differs from the observed in vivo rate (1). 
A more reliable estimate of the effects of high enzyme concen-
trations on this system is obtained by experimental measurement. This 
study measures the extent of the MDH and CS reactions with combina-
tions of dilute and concentrated enzymes. 
Experimental 
Materials 
NAD+, Tris-base, LiCoA, and DTNB were purchased from the Sigma 
Chemical Company; malate and oxaloacetate were from Calbiochem; 
ultrapure EDTA was from Schwarz-Mann; and acetic anhydride came from 
the Fisher Scientific Company. Citrate synthase came from Boehringer 
Mannheim GmbH, as did alcohol dehydrogenase. Malate dehydrogenase 
was purchased from the Sigma Chemical Company. 
Methods 
Substrate Preparations. Acetyl-GoA was prepared in 0.1 M Tris 
by the method of Srere (4). The concentration of the acetyl-GoA was 
determined by enzymatic assay with citrate synthase by monitoring 
the release of GoA (4). 
For a short while, NAD+ was further purified on the day it was 
used as described by Holbrook and Wolfe (3). There was no difference 
in the results obtained with either the commercial NAD+ or the 
further purified NAD+, so the purification was discontinued. NAD+ 
was assayed enzymatically with alcohol dehydrogenase by monitoring 
the production of NADH at 340 nm, the absorptivity of which was 6.22 
-1 -1 
mM em . Assays were performed in a 0.1 M Tris-Cl buffer, 1 mM 
EDTA, pH 8.1 containing 0.34 Methanol, 2.4 x 10- 3 mg/ml alcohol 
+ dehydrogenase, and 0.2-0.3 mM NAD . All other substrates were 
prepared, and the pH adjusted the day of the measurement. 
Enzyme Preparations and Assay. Citrate synthase and malate 
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dehydrogenase were both prepared by collecting their ammonium sulfate 
precipitates by centrifugation. The enzyme precipitates were dis-
solved in 0.1 M Tris-Cl, 1 mM EDTA, pH 8.1 and dialyzed against four 
changes of 100 volumes of the same buffer, allowing two to three hours 
between changes. Citrate synthase was assayed at 25°C in the same 
buffer containing 0.5 mM DTNB, 0.05 mM acetyl-CoA, 0.125 mM oxalo-
acetate, and about 5 x 10- 5 mg/ml CS at 412 nm. An absorptivity 
Malate dehydrogenase was assayed at 25°C, also in the same buffer. 
+ The assay included 3.0 mM NAD , 2.5 mM malate, and approximately 2.5 
x 10- 5 mg/ml MDH. Assays were performed at 340 nm and the production 
of NADH monitored. 
Instrumentation. Equilibrium measurements, enzyme assays, and 
substrate assays were performed on a Coleman 124 spectrophotometer 
equipped as described in the phosphofructokinase methods and stopped-
flow spectrophotometer as described in the glucose 6-phosphate 
dehydrogenase methods. 
Results and Discussion 
Equilibrium Effects. 
We have measured the extent of the MDH and CS reactions with 
combinations of dilute and concentrated enzymes. The combinations 
(Table IX) were used to reveal how much of the altered equilibria 
could be attributed to each enzyme. Reaction equilibria were measured 
spectrophotometrically by NADH absorbances, assuming enzyme bound- and 
free NADH-absorptivities are equal (5). Total NADH concentrations 
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TABLE IX 
EQUILIBRIA OF THE MDH AND CS ENZYME CATALYZED REACTIONS AT 25°Ca 
(MDH) I (CS) 
DID CID DIG CIC 
10 4 App Keq• M 0.88 5.6 - 6.1 0.9 - 1.0 7.7 
Total (NADH) in 
Step 1, ]1M 9.4 24.0 -25.0 9.5 -10.0 28.0 
l;(NADH) with cs, ]1M 0 0 10. 2 -10. 3 12.0 
f'.. (NADH) I (AcCoA) 0.59 0. 34- 0.38 0.81- 0.85 0.70 
~easurements were performed in 0.1 M Tris-Cl, 1 mM EDTA, pH 8.1 using 
dilute enzymes (D = 0.0007 and 0.00029 mglml of MDH or CS, respective-
ly) or concentrated enzymes (C = 2.4 and 1.0 mglml of MDH or CS, 
respectively. This corresponds to 69 ]1M binding sites of MDH and 23 
]1M binding sites of CS.) The app Keq (NADH) 2 , while f'..(NADH) 
(malate)(NAD+) 
with CS is the increase in NADH total concentration when concentrated 
CS is added to the cuvette (Step 2). The 6(NADH)I(AcCoA) is the 
change in NADH concentration (Step 3-Step 2) divided by the 10 f.IM 
acetyl-GoA added in Step 3. 
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were thus calculated from the three steps of each experiment in the 
double-beam spectrophotometer as follows, where+ indicates additions 
to the solution of the previous step. The volume increments in steps 
2 and 3 were less than or equal to 10 percent of the volume in step 1. 
Step SamEle Beam Cuvette Reference Beam Cuvette 
1 MDH + NAD+ + Malate MDH 
at Reaction Equilibrium 
2 + cs + cs 
3 + 10 ]1M Acetyl-CoA + 10 ]JM Acetyl-CoA 
These measurements were made for each of the combinations of 
concentrated (C) and dilute (D) enzyme concentrations summarized in 
Table IX. + Initial substrate concentrations were 3.0 rnM NAD and 0.5 
rnM malate (physiological levels) in all experiments, and enzyme 
concentrations were (mg/rnl): concentrated enzymes, 2.4 (MDH) and 1.0 
(CS), and dilute enzymes, 0.0007 (MDH) and 0.00029 (CS). This enzyme 
ratio of 2 units MDH/unit CS corresponds closely to the cellular 
ratios of mitochondrial activities as measured in Srere's lab on several 
mammalian tissues. MDH units in this context refer to the malate 
oxidation direction. 
Table IX indicates that concentrated MDH alone alters the extent 
of the reaction extensively (7-fold increase in the apparent Keq and a 
2.6-fold increase in NADH), presumably by binding NADH and oxaloacetate. 
The relative amounts of these two bound products are unknown. Thus, 
the free concentrations are also unknown, although the product of the 
latter [(NADH)(oxaloacetate)] is known. Although the competitive 
binding of NAD+ and malate substrates reduces the extent to which the 
products NADH and oxaloacetate bind, only the products are effective 
in altering the reaction equilibrium, since the substrate concentra-
tions are so high relative to enzy~e concentrations. Addition of 
concentrated CS increases the NADg concentration 10-12 ~M whether 
with dilute or concentrated MDH, presumably by binding oxaloacetate. 
Except with the combination C-MDH/D-CS, 10 ~M acetyl-CoA causes about 
6-8 ~M production of NADH. Binding of oxaloacetate to C-MDH would 
explain the low yield of the exception. 
Kinetic Effects 
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Alterations in the equilibrium concentrations of NADH and oxalo-
acetate will extensively alter the kinetic response of the above system 
to the addition of acetyl-CoA (Step 3 in the above experiments). This 
was shown experimentally with dilute enzymes by simply changing the 
substrate (NAD+ and malate) concentrations. Increased substrate 
concentrations give increased product concentrations at equilibrium. 
The latter cause the MDH reaction to respond slower to acetyl-CoA 
addition, although the CS reaction is initially faster. The slower 
response of the MDH reaction is a consequence of the opposing forward 
and reverse reactions. With dilute products, 10 ~M acetyl-CoA and the 
CS reaction cause rapid decrease of oxaloacetate to near zero and the 
MDH reaction responds with near maximal (initial velocity) rates. 
With high product concentrations, the CS reaction does not disequili-
brate the MDH reaction as extensively, and the latter responds closer 
to equilibrium (zero) net rates. In a more continuous situation, the 
rate of oxaloacetate regeneration will ultimately limit the CS reaction 
rate. 
The binding of NADH and oxaloacetate to high MDH and CS concen-
trations could also alter the kinetic properties of the reactions 
relative to those with dilute enzymes. For example, if oxaloacetate 
were rapidly and extensively bound to CS, the reverse MDH reaction 
would be small, and oxaloacetate would be more rapidly regenerated. 
Stopped-flow experiments with combinations of dilute and concen-
trated enzymes (as with the above equilibrium measurements) were 
planned to characterize these kinetic properties. Previous attempts 
to obtain these data (along with ATP effects) utilized a distribution 
of reactants in the two drive syringes as follows, where [A] + [Bl 
means the mixing of solution A in syringe 1 against solution B in 
syringe 2, and OAA is oxaloacetate. 
[MDH + Malate + NAD+ + (equilibrium OAA + NADH)J + [CS ± acetyl-CoAl 
The two fold dilution of the syringe components upon mixing, however, 
altered the binding equilibria to MDH causing a MDH reaction in the 
absence of acetyl-CoA. (This does not occur with dilute enzymes.) 
Technical limitations (variations in dead-time from one mixing shot 
to another, and the rapid rates involved) made the simple subtraction 
of the reaction without acetyl-CoA from the reaction with acetyl-CoA 
inaccurate. Thus immediately following the equilibrium measurements, 
we attempted the following measurements hoping that the equal concen-
tration of enzymes before and after mixing would reduce, if not 
eliminate, the MDH reaction in the absence of acetyl-CoA • 
. [MDH +Malate+ NAD+ + CS +(equilibrium OAA and NADH)J + 
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[MDH + CS ± acetyl CoAl 
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The reaction without acetyl-GoA with this distribution was much greater 
than with the previous distribution, however. Quantitative calcula-
tions of the binding equilibria before and after mixing, assuming 
simple binding of NADH with known binding constant, showed that this 
could occur. In the first arrangement, the effects on the binding 
equilibria of a reduction in product concentrations were partially 
cancelled by the effects of a reduction in enzyme concentrations. 
The equal reduction in substrate and product concentrations prevents 
a MDH reaction with dilute enzymes where enzyme bound reactants are 
negligible. 
Since a high volume ratio mixing capability is needed for further 
measurements on this system, further investigation has been postponed. 
Summary and Conclusion 
Using physiological levels of malate and NAD+ (0.5 mM and 3.0 
mM respectively) along with both concentrated and dilute solutions 
of both MDH and CS in the ratio of 2/1 which closely corresponds to 
the ratio found within the cell, we find that concentrated MDH causes 
a 7-fold increase in the apparent Keq and a 2.6-fold increase in NADH, 
we presume through the binding of NADH and OAA to the MDH enzyme. The 
addition of concentrated CS increases the concentration of NADH by 
10-12 ~M, also presumably through binding, this time of oxaloacetate. 
Thus we find that the concentrated enzymes alter equilibria through the 
binding of larger amounts of metabolites. 
Increased concentrations of substrates cause a decrease in the 
response rate of the MDH to acetyl-GoA addition although the initial 
response of the CS is more rapid. In the continuous situation, the 
rate of OAA regeneration will, however, ultimately limit the CS 
reaction. When the enzymes are present at high concentrations, the 
OAA is more extensively bound to the CS and OAA is more rapidly 
regenerated thus leading to a more tightly coupled system. This has 
implications for the TCA cycle in that the binding of the metabolites 
changes the kinetics and observations with the dilute enzyme system. 
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CHAPTER IV 
RAT LIVER GLUCOSE 6-PHOSPHATE 
DEHYDROGENASE 
49 
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Introduction 
The enzyme glucose 6-phosphate dehydrogenase (D-glucose 6-phos-
phate: NADP+ oxidoreductase, EC 1.1.1.49), G6PD, catalyzes the 
following conversion: 
!3-D-glucopyranose 6-P + NADP+ + D-gluconolactone 6-P + NADPH + H 
This reaction represents the first step in the pentose phosphate path-
~ 
way, functions of which are the production of pentose phosphate sugars 
for the synthesis of nucleotides and for the production of NADPH for 
various reductive processes, especially fatty acid biosynthesis, and 
in erythrocytes for the regeneration of hemoglobin from methemoglobin 
(1). 
The activity of the enzyme in the liver increases significantly 
upon feeding a high carbohydrate diet following a period of fasting 
(eg. 2-7). Subsequent feeding of fats causes the G6PD activity to 
decrease (8,9,10), whether by a decrease in appetite and thus food 
intake as suggested by Gozukara et al. (8) or by some other method 
than reduction in appetite as suggested by the results of Nace and 
Szepesi (9). 
There are two interpretations of the nutritionally induced in-
creased G6PD activity in liver. First, is that the increase in 
activity is due to increased synthesis of the enzyme with a concomitant 
increase in the amount of G6PD protein, and a decrease in activity is 
accompanied by a decrease in the amount of protein (3,8); second, that 
new protein is synthesized thus increasing the enzymatic activity, with 
a constant amount of protein regardless of the ,enzymatic activity 
(11,12,13). They claim that feeding of fats causes a decrease in the 
activity of G6PD by converting enzymatically active G6PD protein to an 
inactive form, while total G6PD protein measured by specific titration 
with G6PD antibody remains constant. 
Eggleston and Krebs (1) confirmed the inhibition of G6PD by 
NADPH and showed that it is competitive with respect to NADP+. The 
inhibition of the G6PD depends on the ratio of the NADPH concentra-
tion to the NADP+ concentration, such that at cellular concentrations 
of these nucleotides, Eggleston and Krebs believe that the enzyme 
would be completely inhibited, although Thompson et al. calculate 
significant activity even if the enzyme is 98 percent inhibited (14). 
Eggleston and Krebs found that GSSG added to rat liver supernatants 
at normal tissue concentrations reversed this inhibition. The 
supernatant when dialyzed against water did not lose activity, but 
lost the ability to reverse the inhibition due to NADPH when GSSG 
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was added. Thus they believe there is some dialyzable cofactor that 
relieves NADPH inhibition of the enzyme under intracellular conditions. 
G6PD from yeast is a tetramer containing four moles of NADP+ 
(15) and is dissociable to dimers having a molecular weight of 
102,000 (16). The dimer specie is catalytically active. The erythro-
cyte enzyme is similar to the yeast enzyme in that it exists as 
tetramers and dimers both of which are active (17). The molecular 
weights are similar with the monomeric subunit having a molecular 
weight of about 50,000 and no catalytic activity. The mammary gland 
G6PD also exists as a dissociable tetramer (18). Holten found rat 
liver G6PD existing as active dimers, tetramers and hexamers with 
molecular weights of 130,000, 280,000, and 370,000 respectively (19). 
Monomers of 64,000 are without activity. 
The erythrocyte enzyme shows concentration dependent properties 
with only twe~ty-five percent of maximal activity in the range of 
0.0007 to 0.3 mg G6PD/ml. Maximal activity was expressed only with 
enzyme concentrations greater than 2 mg/ml (20). The mammary gland 
G6PD requires a minimum concentration of 0.4 mg/ml in order to form 
the tetrameric form of the enzyme (18). 
Yugari and Mats~da reported inhibition of purified rat liver 
G6PD by free fatty acids (10). The inhibition is competitive with 
+ respect to NADP , but once the enzyme is inhibited, the inhibition 
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is reported to b!'! irreversible. Taketa and Pogell reported inhibition 
of purified yeast G6PD and G6PD in rat liver supernatants by palmitoyl-
GoA (21). They found that the extent of inhibition was dependent upon 
the concentration of the enzyme, and that the inhibition was prevented 
but not reversed by the addition of BSA. There was a fast inactivation 
of the yeast G6PD by palmitoyl-GoA during the first five minutes of 
incubation together, followed by a slow inactivation during the second 
five minutes. They concluded that the inhibition was nonspecific in 
that it affected several enzymes, that it was just a detergent effect, 
and of little physiological significance. 
Kawaguchi and Block, in studying the yeast G6PD, found that 
palmitoyl-GoA dissociates the tetr~meric G6PD to dimers (15). When 
SDS was used to dissociate the enz~me to monomers, there was no 
difference in the affinity of the monomer or the dimer for palmitoyl-
GoA. It was possible to induce re~ggregation qf the dimeric enzyme 
after removal of the palmitoyl-GoA, although the reaggregated tetramer 
was only one-third as active, and contained no NADP+. 
Current literature data on liver G6PD are deficient in several 
areas. The liver enzyme extensively associates at concentrations 
near cellular values, yet the catalytic properties of these oligomers 
have not been studied. Varying enzyme concentrations at even lower 
values greatly modifies its inhibition by palmitoyl-CoA. Current 
available data, however, are too limited to quantitatively evaluate 
palmitoyl-CoA inhibition of G6PD at various enzyme concentrations. 
Although palmitoyl-CoA appears to inhibit several enzymes, this need 
not preclude its significant effects. Palmitoyl-CoA is present in 
the cell at high concentrations, thus it is desirable to understand 
to what extent and how it affects G6PD. The rat liver enzyme used 
for previous studies has generally been from crude dialyzed extracts. 
Since there are several enzymes with high specificity for degrading 
G6PD (22) (and probably palmitoyl-CoA also), experiments are needed 
with a more purified system. Also most previous studies of G6PD 
have used Tris buffers. 
Our overall goals, therefore, are to evaluate the enzyme's 
catalytic properties using a more purified enzyme and more physio-
logical conditions. This thesis project, however, deals principally 
with the palmitoyl-CoA inhibition of G6PD. 
Experimental 
Materials 
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KH 2 P0 4 and zinc acetate were purchased from the Fisher Scientific 
Company; KCl, acetic acid, and ammonium hydroxide were from the J. T. 
Baker Chemical Company; and MgCl 2 was from Mallinckrodt. Ultrapure 
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EDTA and (NH4) 2 S04 were purchased from Schwarz-Mann; absolute ethanol 
came from the U. S. Chemical Company. G6P, NADP+, palmitoyl-CoA, BSA, 
Tris base, 2-mercaptoethanol, and fluorescein isothiocyanate were 
supplied by Sigma; CM cellulose was purchased from Reeve Angel while 
DEAE cellulose was purchased from both Reeve Angel and Sigma. 
Rats were obtained from Holtzman and were kept in the Biochemr 
istry Animal Facility until needed. High carbohydrate-low fat diet 
was purchased from Teklad Test Diets of Madison, Wisconsin and 
consisted of 300 g/kg vitamin free casein, 600 g/kg sucrose, 55 g/kg 
cellulose, 35 g/kg Williams-Briggs modified mineral mix, and 10 g/kg 
Teklad vitamin mix. 
Methods 
Enzyme Purification. The procedure followed in the purification 
of the G6PD from rat liver is like that of Matsuda and Yugari (12) 
and Holten (18,23) with a few modifications. If after decanting the 
supernatant from the ultracentrifugation step, fat was carried over 
into the supernatant, the solution was strained through several layers 
of cheese cloth to remove the fat. The overnight dialysis of the 
enzyme against glass distilled water was changed to two 30-45 minute 
dialyses against two liters of glass distilled water containing 
10- 4 M NADP+. The carboxymethyl-cellulose column was eluted with a 
linear gradient of 750 ml of 20 mM ammonium acetate, 0.1 mM EDTA, 
-4 + 10 M NADP , 5 mM 2-mercaptoethanol, pH 5.5 and 750 ml 50 mM potas-
-4 + sium phosphate, 0.1 mM EDTA, 10 M NADP , 5 mM 2-mercaptoethanol, 
pH 7.0. 
Assay. Standard conditions for determining maximal activity of 
+ G6PD are 0.1 M Tris-Cl, 0.1 mM EDTA, 0.8 mM G6P, 0.2 mM NADP , 2.8 
mM MgCl 2 , pH 8.0. The enzyme actiyity is determined spectrophoto-
metrically at 340 nm and 25°C. The activity was calculated using a 
value of 6.22 mM- 1 cm- 1 for the absorptivity of NADPH. One unit of 
enzyme is defined as the conversion of one ~mole of NADP+ to NADPH 
per minute. 
Protein Determination. Protein concentrations were determined 
by the Lowry method (24). BSA was used as the protein standard. 
Reagent Preparations. The substrate solutions were made and 
the pH adjusted the same day they were used. MgC1 2 used in assays 
was purified by the method of Morrison and Uhr (25). 
Instrumentation. A Coleman 124 spectrophotometer equipped as 
described in the phosphofructokinase section was used to perform 
standard and dilute enzyme assays. Measurements using more concen-
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trated enzyme or requiring fast mixing, were made with a Durrum-Gibson 
stopped-flow spectrophotometer with either a tungsten light source 
or a mercury-xenon light source. Temperature control was accomplished 
using a Forma model 2095-2 bath and circulator. Data were recorded 
on a Tektronix storage oscilloscope. Fluorescence measurements were 
made in a thermostatted Aminco-Bowman spectrophotofluorometer with 
a mercury-xenon light source and with 3 mm slit widths. Fluorescence 
depolarization measurements were performed with the Durrum-Gibson 
stopped-flow spectrophotometer equipped with a fluorescence accessory. 
The light source used was an argon ion laser. Sedimentation velocity 
measurements were made with a Beckman Model E ultracentrifuge. 
Stopped-Flow Measurements. Stopped-flow measurements are per-
formed using two drive syringes, portions of the reaction components 
being placed in each syringe. When a pneumatic plunger is activated, 
the contents of the two syringes are mixed, with a reaction dead-time 
of about three milliseconds. 
Fluorescent Labelling. Rat liver G6PD was labelled with fluo-
rescein isothiocyanate by the method of Shore and Chakrabarti (26). 
After labeling, the enzyme was ·exchanged into a 0. 01 M potassium 
phosphate, 0.01 M NaCl, 0.12 M KCl, 0.1 rnM EDTA, pH 7.4 buffer using 
a Sephadex G-25 column. The degree of labelling was determined by 
the absorbance at 490 nm, using an absorptivity of 3.4 x 10 4 M- 1 cm- 1 
as described by Shore and Chakrabarti (26). The extent of labelling 
calculated from our data was 0.5 molecule of fluorescein per equiva-
lent of 64,000 molecular weight G6PD monomer. 
Results and Discussion 
56 
The studies of both Taketa and Pogell (21) and Kawaguchi and 
Bloch (15) concerning the palmitoyl-CoA inhibition of G6PD were done 
in a Tri~-HCl buffer system, which may or may not have affected their 
results. We preferred instead to use a potassium phosphate buffer 
system in that it more closely approximates intra~ellular conditions. 
After a few preliminary measurements, we increased the ionic strength 
of the buffer by the addition of KCl, and NaCl in the amounts that one 
would expect to find in the cell. Substrate concentrations were 
adjusted to conform with those estimated to exist in the cell by 
57 
Greenbaum et al. (27). Thus the studies presented here should be more 
significant because of the more nearly physiological conditions under 
which they were performed. 
Both groups previously mentioned concerned themselves with yeast 
enzyme and Taketa and Pogell also considered rat liver G6PD. The 
enzyme however came from rat liver supernatants prepared by centri-
fugation followed by overnight dialysis. Since there are three 
enzymes specific for the inactivation of G6PD (22), the results 
obtained with the rat liver supernatant are subject to question. 
G6PD-Specific Activity Dependence on Assay 
Conditions 
Comparison of various assay compositions on the specific activity 
is shown in Table X. As would be expected, the activity in the Tris-Cl 
buffer, pH 8.0 is greatest since it is at the pH optimum of the enzyme 
and saturating substrate concentrations. Assay of the enzyme in a 
10 mM potassium phosphate buffer with a pH of 7.4 (that expected in 
the cytoplasm) and substrate concentrations expected within the cell 
gives a specific activity that is 67 percent of that with the Tris 
system at pH 8.0. MgCl 2 , an accepted activator of G6PD, appears to 
cause a decrease in the specific activity (Table XI) when assayed in 
a 10 mM potassium phosphate, 0.12 M KCl, 10 mM NaCl, 0.1 mM EDTA, 
pH 7.4 buffer. This leads one to question whether the MgC1 2 acti-
vation of G6PD observed in other assay systems has physiological 
significance. BSA in amounts as small as 2.5 ~g/ml is found to lead 
to increased activity over enzyme incubated overnight with NADP+ but 
no BSA (Table XII). 
TABLE X 
ENZYME-SPECIFIC ACTIVITY VARIATION WITH ASSAY CONDITIONSa 
Assay Buffer Substrates MgC1 2 Salt pH Specific Activity 
A 0.1 M Tris-Cl 0.80 mM G6P 2.8 mM - 8.0 71.6 
0.39 mM NADP+ 
B 0.01 M potassium 0.80 mM G6P 2.8 mM 0.12 M KCl 7.4 59.6 
phosphate 0. 39 mM NADP+ 0.06 M NaCl 
c 0.01 M potassium 0.80 mM G6P - 0.12 M KCl 7.4 63.4 
phosphate 0.39 mM NADP+ 0.01 M NaCl 
D 0. 434 M potassium 0. 434 mM G6P - 0.12 M KCl 7.4 48.0 
phosphate 0. 01 mM NADP+ 0.01 M NaCl 
aThe G6PD concentration in the assays was 0.485 ~g/ml. All assays were performed at 25°C, and were started 
by the addition of G6P to the assay cuvette. 0.1 mM EDTA was added to all assays. 
Vt 
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TABLE XI 
THE EFFECT OF MgC1 2 ON G6PD SPECIFIC ACTIVITY IN A HIGH IONIC 
STRENGTH PHOSPHATE BUFFERa 
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0 
MgC1 2 , roM 
0.005 0.01 0.05 0.10 0.20 1.0 3.0 5.0 10.0 
S .A. 32. 7 25. 9 26.2 26. 2 25. 4 2 7. 7 25. 7 24. 9 20.0 22.8 
aThe G6PD concentration in the assays was 0.62 ~g/m1. The assays were 
performed at 25°C and were started by the addition of G6P to the assay 
cuvette. The assay system contained 0.01 M potassium phosphate, 0.12 
M KC1, 0.01 M NaC1, 0.1 roM EDTA, 0.434 roM G6P, 0.01 roM NADP+, pH 7.4. 
TABLE XII 
THE BSA EFFECT ON SPECIFIC AC'J;'IVITY UPON OVERNIGHT INCUBATIONa 
BSA, f.lg/m1 
0 2.5 25.0 250.0 1000.0 
S .A. 24 32.2 32.5 35.3 34.1 
aThe G6PD concentration was 0.97 ~g/m1. The incubations and assays 
were performed at 25°C with 0.01 M potassium phosphate, 0.12 M KC1, 
0.01 M NaC1, 0.1 roM EDTA, 0.01 roM NADP+, pH 7.4. The reaction was 
started by adding G6P to make the mixture 0.434 roM, after overnight 
(10-12 hr) incubation. 
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Palmitoyl-CoA Inhibition 
Palmitoyl-CoA inhibits the G6PD when incubated with the enzyme and 
NADP+ as shown in Table XIII. With 0.9 ~g enzyme/ml, 2 ~M palmitoyl-
CoA reduces the activity of the enzyme to about 54 percent of the 
activity of the control (the assay without palmitoyl-CoA) while 10 ~M 
palmitoyl-CoA reduces the activity to about 6 percent. While palmitoyl-
CoA inhibits G6PD, we found an apparent enhancement of the activity 
of G6PD by 1 ~M palmitoyl-CoA (Table XIV) when compared to the control 
(the first entry in Table XII). 
MgClz Reversal of Palmitoyl-CoA Inhibition 
The palmitoyl-CoA inhibition of G6PD activity was reversed by 3 
mM MgC1 2 (Table XIII) in dilute enzyme assays presumably by precipi-
tating the palmitoyl-CoA. In overnight incubations of the enzyme and 
palmitoyl-CoA with MgC1 2 , 1.0 mM MgC1 2 appeared to remove the inhi-
bition by the palmitoyl-CoA (Tables XIV and XV). This was disturbing, 
as intracellular concentrations of Mg 2 + are about 1 mM (28) and the 
significance of the palmitoyl-CoA inhibition is questionable if this 
concentration of MgCl 2 abolishes the inhibition. Overnight incubation 
of the enzyme with palmitoyl-CoA, 0.01 mM NADP+, and 1.0 mM MgClz .at 
37°C shows that inhibition by palm~toyl-CoA at concentrations greater 
than or equal to 4 ~M is not relieved by the MgCl 2 (Table XVI). 
Protection from Palmitoyl-CoA Inhibition by BSA 
We found that BSA at concentrations as low as 2.5 ~g/ml appears 
to lead to an increased G6PD activity compared to the control when 
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TABLE XIII 
PERCENT ACTIVITY OF ENZYME AS EFFECTED BY MgCl 2 AND PALMITOYL-CoA8 
MgC1 2 Pa1mitoyl-CoA, 11M 
mM 0 1.0 2.0 3.0 4.0 5.0 10.0 
0 100 98.1 53.7 36.8 5.8 
3.0 100 104.7 99.4 97.0 101.4 105.8 
aThe G6PD concentration in the assays was 0.9 )lg/ml. The assay mixture 
containing 0.01 M potassium phosphate, 0.1 mM EDTA, 0.078 mM NADP+, 
enzyme, and MgC1 2 and palmitoyl-CoA as indicated was incubated at 25°C 
for 5 minutes before adding G6P to make the mixture 0.434 mM in G6P to 
start the reaction. 
TABLE XIV 
PALMITOYL-CoA AND MgC1 2 EFFECT ON ENZYME-SPECIFIC ACTIVITY 
UPON OVERNIGHT INCUBATIONa 
Palmitoyl-CoA MgC1 2 , mM 
11M 0 0.1 1.0 
1 33.9 33.6 30.2 
10 0 22.8 
~he G6PD concentration in the incubations and assays was 0.97 )lg/m1. 
The incubation a~d assay mixture contained 0.01 M ~otassium phosphate, 
0.12 M KCl, 0.01 M NaCl, 0.1 mM EDTA, 0.01 mM NADP , pH 7.4 plus 
enzyme and indicated conditions, and was kept in 25°C overnight (10-12 
hr). The reaction was initiated by making the mixture 0.434 mM in 
G6P. . 
TABLE XV 
THE EFFECT OF MgCl 2 AND BSA ON THE PALMITOYL-CoA INHIBITION OF 
G6PD UPON OVERNIGHT INCUBATION AT 25°Ca 
MgCl2 BSA, ]Jg/ml 
mM 0 2.5 25.0 250 1000 
0 0.22 7.4 33.0 34.1 
0.1 0 0.3 6.6 34.2 35.8 
1.0 22.8 21.8 25.6 34.4 32.8 
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aThe G6PD concentration in the incub.;~.tion assay mixture was 0. 97 pm/ml. 
The mixture contained 0.01 M potassium phosphate, 0.12 M KCl, 0.01 M 
NaCl, 0.1 mM EDTA, 0.01 mM NADP+, 10 ]JM palmitoyl-CoA, plus indicated 
additions and enzyme at pH 7.4. Th~ mixture was incubated overnight 
(10-12 hr) at 25°C and the reaction was started by making the mixture 
0.434 mM in G6P. Specific activities are reported. 
0 
37.7 
TABLE XVI 
SPECIFIC ACTIVITY OF G6PD UPON OVERNIGHT INCUBATION AT 37°C 
WITH PALMITOYL~CoA AND MgC1 2 a 
Palmitoyl-CoA, ~M 
1.0 2.0 3.0 4.0 s.o 6.0 7.0 8.0 
43.9 39.0 23.2 3.2 2.0 1.4 1.3 
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aThe G6PD concentration used was 0.97 ~g/ml. The incubation-assay 
mixture contained 0.01 M potassium phosphate, 0.12 M KCl. 0.01 M NaCl, 
0.1 mM EDTA, 1.0 mM MgC1 2 , 0.01 mM NADP+, enzyme, and palmitoyl-CoA as 
indicated, all at pH 7.4. The reactions were started after overnight 
incubation at 37°C by making the mixture 0.434 mM in G6P. All concen-
trations of palmitoyl-CoA greater than 8 ~M gave zero specific 
activities. 
incubated overnight at 25°C (Table XII). With 10 JJM palmitoyl-CoA 
present in the overnight incubation mixture, however, 250 ]Jg BSA/ml 
was required to provide the same activity that was observed with no 
palmitoyl-CoA and 2.5 ]Jg BSA/ml (Table XV). It appears that the BSA 
may adsorb the palmitoyl-CoA and that higher concentrations of BSA 
are required to effect this. 
The Effects of Palmitoyl-CoA Concentr~tion, 
Time, and Enzyme Concentration 
The inhibition of G6PD by palmitoyl-CoA is dependent upon the 
concentration of the palmitoyl-CoA incubated with the enzyme and upon 
the time of incubation (Figure 3). Increasing the palmitoyl-CoA 
concentration causes an increase in the rate with which inhibition 
develops. When the G6PD concentration is increased 10-fold, the 
expression of the palmitoyl-CoA inhibition is at a rate slower than 
that with the more dilute enzyme (Figure 4). Thus the inhibition of 
G6PD by palmitoyl-CoA is dependent upon the palmitoyl-CoA concen-
tration, the time, and the concentration of the enzyme. 
Incubation of Substrates with G6PD 
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The incubation of one of the sub~trates with the G6PD followed by 
the initiation of the reaction with palmitoyl-CoA and the other sub-
strate gives activities that do not ~hange with time of incubation, but 
instead depend upon the substrate with which the enzyme was incubated 
and the concentration of the palmitoyl-CoA. Figure 5 shows results 
from stopped-flow measurements of this nature, which provide a measure 
of the fast phase of inhibition. Initial velocities are obtained 
Figure 3. The Dependence of G6PD Activity on Time and on Palmitoyl-
CoA Concentration with 0.7 ~g Enzyme/ml. Syringe I 
contained G6PD, 0.078 mM NADP+, and pa1mitoy1-CoA as 
indicated. Syringe II contained 0.434 mM G6P, 0.010 
mM NADp+, and palmitoy1-CoA as indicated. The buffer 
in both syringes was 10 mM potassium phosphate, 0.12 
M KC1, 10 mM NaC1, 0.1 mM EDTA, pH 7.4. The incubation 
time is the time that the G6PD was incubated with the 
contents of Syringe I before the contents of the two 
syringes are mixed to start the reaction. The incu-
bation and reaction are carried out at 25°C. Pa1mitoyl-
CoA concentrations were: 0 ~M, 0--0; 10 ~M, []--[]; 
20 ~M, ~--~; 30 ~M, t--t; and 50 ~M, 11--11. 
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Figure 4. The Dependence of G6PD Activity on Time and Palmitoyl-
CoA Concentration with 7 ~g Eznyme/ml. Conditions are 
identical to those of Figure 3. Palmitoyl-CoA concen-
trations are: 0 ~M, 0--0; 10 ~M, []--[] ; 30 ~M, 
1--1; and 50 ~M, •-•. 
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Figure 5. The Dependence of Pa1mitoy1-CoA Inhibition Upon G6PD In-
cubation with Substrate. Assay buffer used was 10 mM 
potassium phosphate, 0.1 mM EDTA, pH 7.4. Incubation 
conditions were, [Syringe 11 and [Syringe 21 : [9 ~g 
G6PD/m1 + 0.078 mM NADP+] and [0.078 mM NADP+ + 0.434 
mM G6P + 10 ~M pa1mitoy1-CoA], 0--0; [9 ~g G6PD/m1 + 
0.434 mM G6P] and [0.078 mM NADP+ + 0.434 mM G6P + 10 
~M pa1mitoy1-CoA], []--[]. 
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within the first 0.5-1.0 second of the reaction. If enzyme is incu-
bated with NADP+, this rapidly expressed inhibition increases to about 
15% with increasing palmitoyl-CoA to about 100 ~M, but higher palmitoyl-
CoA concentrations are much less effective. When the enzyme is incu-
bated with G6P, however, continuously increasing rapid inhibition 
with increasing palmitoyl-CoA concentrations is observed. Above 20 ~M 
palmitoyl-CoA, enzyme inhibition becomes essentially complete at longer 
times whether enzyme is incubated with NADP+ or not (Figure 3). The 
data in Figure 5, therefore, indicate that there are two or more 
sequential kinetic steps in the reaction of palmitoyl-CoA with enzyme. 
NADP+ appears to significantly reduce the rate of one of these trans-
formations. 
Sedimentation Velocity Measurements 
Sedimentation velocity measurements performed with 1 mg G6PD/ml 
in 10 mM potassium phosphate, 0.12 M KCl, 10 mM NaCl, 0.1 mM EDTA, 
-4 + 10 M NADP , pH 7.4 gave a value of 15.7 S. A molecular weight of 
466,000 can be estimated from this s value assuming G6PD is a globular 
protein and using calibration proteins as done in Figure 6. When 100 
~M palmitoyl-CoA was added to this solution, and the measurements 
performed, we obtained two enzyme peaks, one corresponding to 6.4S 
and the second corresponding to 11.6 S. These values correspond to 
molecular weight estimates of 113,000 and 286,000 respectively 
(Figure 4). In addition we observed a hypersharpening of the peaks, 
an indication of an associating system. Thus we observed an apparent 
dissociation of the G6PD by palmitoyl-CoA from an apparent octameric 
form to an apparent dimer-tetramer equilibrium. 
Figure 6. Plot of Log(Molecular Weight) vs. Log(Sedimentation 
Coefficient) for Several Globular Proteins. Proteins 
are: Hemoglobina, 1; Albumina, 2; Diptheria antitoxic 
pseudoglobulina, 3; a-Amylaseb, 4; Concanavalinb, 5; 
Aldolaseb, 6; Catalaseb, 7; Cbtochrome cb, 8; B-
Galactosidaseb, 9; Hemocyanin , 10; Glucose 6-phosphate 
dehydrogenase (see text), 11, 12, 13. 
aData obtained from Cohn, E. J. and Edsall, J. T. 
(1943) Proteins, Amino Acids and Peptides, Reinhold 
Publishing Corporation, New York. 
bnata obtained from Sober, H. A. (1968) Handbook of 
Biochemistry, The Chemical Rubber Co., Cleveland. 
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Fluorescein Labelled G6PD 
The fluorescein labelled G6PD contained 0.5 molecule of fluorescein 
per monomer of enzyme. The labelled enzyme behaved the same as the 
unlabelled enzyme. The rate of expression of the palmitoyl-CoA inhi-
bition depended on the palmitoyl-CoA concentration, the time of 
incubation of the G6PD with palmitoyl-CoA, and the G6PD concentration 
(Figures 7 and 8). 
Incubation of the fluorescein labelled G6PD at 25°C and a 
concentration of 82.0 ~g/ml in a 10 mM potassium phosphate, 0.12 M 
KCl, 10 mM NaCl, 0.1 mM EDTA, pH 7.4 buffer containing 0.01 mM NADP+ 
led to a 50 percent increase in fluorescence overnight. This also 
occurred when 10 ~M palmitoyl-CoA was added to the mixture. Depolari-
zation measurements were attempted with the hope that they would 
reveal a dissociation of the enzyme that paralleled the palmitoyl-CoA 
inhibition. We observed total depolarization of the enzyme even before 
the addition of the palmitoyl-CoA. We believe that we had tetrameric 
enzyme labelled with two molecules of fluorescein. Energy transfer 
between like molecules on an enzyme does not lead to fluorescence 
quenching, but instead leads to depolarization (29). We believe this 
is why we observed the total depolarization, which prevents us from 
monitoring enzyme dissociation with this fluorescence probe. 
Enzyme-Concentration-Dependent Specific Activity 
We hope that in the near future we will be able to perform light 
scattering measurements to correlate the enzyme inhibition with a 
dissociation of the enzyme. A laser light scattering instrument, 
Figure 7. The Dependence of Fluorescein-Labelled-G6PD Activity on 
Time and on Palmitoyl-CoA Concentration with 0.672 ~g 
Enzyme/ml. Conditions are described in Figure 3. 
Palmitoyl-CoA concentrations are: 0 ~M, 0--0; 10 ~M 
D--0; 20 ~M, !J.-!J.; 30 ~M, 1--1. 
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Figure 8. The Dependence of Fluorescein-Labelled-G6PD Activity on 
Time and on Palmitoyl-CoA Concentration with 6.72 ~g 
Enzyme/ml. Conditions are described in Figure 3. 
Palmitoyl-CoA concentrations are: 0 ~M, 0--0; 20 ~M, 
l:1-A; 30 ~M, 1-1; 50 ~M, ·--·. 
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such as that manufactured by Chromatix, Mountain View, California, will 
be needed, however, to give the desired sensitivity with sufficiently 
small volumes to be practical. Our current Phoenix-Brice instrument 
requires large volumes (about 30 m1 in comparison to a few tenths for 
the laser instruments) and thus excessively large quantities of enzyme. 
We observed an apparent dependence of the G6PD upon its 10-fold 
increase in concentration (Table XVII). This apparent concentration 
dependence was observed with both unlabelled and fluorescein labelled 
enzyme. Thus protein-protein interactions play a role in determining 
the enzyme activity. 
Proposed Model 
The ultracentrifugation data indicate that we have three molecular 
weight species. This along with the palmitoyl-CoA inhibition data 
leads us to propose a model along the following lines: 
____,. EE ~ ~ ..._.--
PCoAJr PCoA Jf 
Etr PCoA ----"'- CJO ..,...-
PCoAlf 
00 
Hexameric and higher forms can occur and equilibrate with tetrameric 
and dimeric forms of the enzyme amounts of each form depending on the 
enzyme concentration. The binding constant for palmitoyl-CoA must be 
higher with the dimeric form of the enzyme than the tetrameric form. 
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TABLE XVII 
THE DEPENDENCE OF SPECIFIC ACTIVITY ON ENZYME CONCENTRATIONa 
F1uorescein-G6PD G6PD 
]lg/m1 ).lg/m1 Specific Activity 
0.7 90.8 
7 109.8 
0.672 88.4 
6.5 120.3 
~he assays were performed in a 0.01 M potassium phosphate, 0.12 M KC1, 
0.01 M NaC1, 0.1 mM EDTA, pH 7.4 buffer at 25°C. The assay contained 
0.434 mM G6P and 0.01 mM NADP+ and was initiated by mixing [G6PD + 
NADP+] + [G6P + NADP+] • 
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The conformational change induced by the palmitoyl-CoA is rapid and is 
followed by a slower dissociation of the enzyme and binding of pal-
mitoyl-CoA to totally inactivate it. Activation of the enzyme by BSA 
alone is possibly by protein-protein interactions stabilizing higher, 
and more active, molecular weight forms of the enzyme. Palmitoyl-CoA 
at a concentration where we notice an apparent activation of the G6PD 
does not exist in a micellular form as it does at higher concentrations 
and it is probably the micellular form that is inhibitory (30). 
Summary and Conclusion 
The question of whether palmitoyl-CoA can be considered as an 
inhibitor of any physiological importance in light of its reversal 
at 25°C by cellular concentrations of MgC1 2 can be answered affirma-
tively as incubation at 37°C allows the expression of the palmitoyl-CoA 
inhibition. The palmitoyl-CoA inhibition of rat liver G6PD depends 
upon the enzyme concentration, the palmitoyl-CoA concentration, the 
incubation time before initiating the reaction, and if the enzyme is 
incubated in the absence of palmitoyl-CoA, the substrate with which it 
is incubated. We also notice an increased specific activity of the 
enzyme with increased enzyme concentration. This leads us to propose 
a model involving a conformational change induced by the palmitoyl-CoA, 
followed by a slow dissociation. 
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